Xiang Rong Li

Xiang Rong Li is currently Independent Non-Executive Director at Viva Biotech (Shanghai) Co., Ltd., Independent Director at Noah Holdings Ltd. since 2024, Non-Executive Director at Chongqing Taiji Industry (Group) Co., Ltd. starting 2025, Director at China National Pharmaceutical Group Co., Ltd. since 2024, Independent Non-Executive Director at Viva Biotech Holdings since 2019, Non-Executive Director at China Traditional Chinese Medicine Holdings Co. Ltd. starting 2025, Deputy GM, Chief Financial & Accounting Officer at BTG Hotels (Group) Co., Ltd. since 2016, Investor Inquiry Officer at Shanghai Xinyu Watch & Clock Group., Ltd., Chief Financial Officer at Hengdeli Group Ltd. since 2010, Member of the Association of Chartered Certified Accountants since 2003, and Member of The Chinese Institute of Certified Public Accountants since 1995.
Former roles include Independent Director at MakeMyTrip Ltd. from 2019 to 2024, Deputy Director-Industry Management Office at Peking University, Director at Beijing Tiantan Biological Products Corp.
Ltd. from 2018 to 2023, Chief Financial Officer at Homeinns Hotel Group from 2014 to 2016, Chief Financial Officer at Hengdeli Holdings Ltd. from 2010 to 2014, Financial Controller-Greater China Region at Unilever (China) Co., Ltd. from 2007 to 2010, and Secretary & Vice President at China National Biotec Group Co., Ltd. from 2018 to 2024.
Education includes an MBA from China Europe International Business School in 2008 and undergraduate and graduate degrees from Peking University.